Medicine and Device Surveillance CRE
Prescription medicines and therapeutic devices when used appropriately offer significant benefit to patients and their health care, however, medicines and medical devices are also associated with significant levels of harm. The Centre of Research Excellence is developing better mechanisms for detecting medicine and device safety signals, quantifying the level of risk from medicines and devices and identifying those at most risk of harm and practice.
A major goal of the Centre is to build the capacity within Australia for medicine and device surveillance as well as pharmacoepidemiological and prosthetic epidemiological research. This project is funded by the National Health and Medical Research Council Grant APP1040938.
Read more about the Medicine and Device Surveillance CRE
The Veterans’ Medicines Advice and Therapeutics Education Services (MATES) program has improved the health of veterans by providing up to date health and medicines information specifically tailored for veterans and their general practitioners. The activities of the Veterans’ MATES program are underpinned by the guiding principles of Australia’s National Strategy for Quality Use of Medicines.
Utilising DVA’s health claims data, Veterans’ MATES provides direct patient-based feedback to general practitioners. This is supported with educational materials developed by a clinical panel which is peer reviewed and overseen by a national representative editorial committee. Pharmacists and veterans also receive supporting educational material. This project is funded by the Australian Government Department of Veterans' Affairs.
Veteran’s MATES website
Optimal ageing for people with multiple chronic conditions
The final report of this Ageing Well, Ageing Productively Strategic Grant funded by the ARC and NHMRC (ID401832) has now been published.
Multiple chronic health conditions in older people: Implications for health policy planning, practitioners and patients (PDF 1MB)
Development and evaluation of novel anti-inflammatory products derived from an Indigenous medicinal plant
Collaborative projects between Centre researchers and Indigenous traditional owners from Northern Kaanju homelands (Cape York Peninsula, Qld) aim to develop and evaluate products derived from the Northern Kaanju medicinal plants. Extracts of these plant and novel compounds isolated from them have anti-inflammatory activity. These have the potential to be used in inflammatory diseases such as dermatitis, arthritis and inflammatory bowel disease.